Effect of an Empowerment-Based Psychoeducation Program on Burnout and Psychological Outcomes in Nurse Managers

This randomized controlled trial aims to evaluate the effectiveness of an empowerment-based psychoeducation program on burnout, self-leadership, mindfulness, and psychological resilience among nurse managers. The study population consists of nurse managers working in healthcare settings. The primary objective of this study is to determine whether the psychoeducation program reduces burnout levels and improves self-leadership, mindfulness, and psychological resilience among nurse managers. The main research questions are as follows: Does the empowerment-based psychoeducation program reduce burnout levels in nurse managers? Does the program improve self-leadership levels in nurse managers? Does the program increase mindfulness levels in nurse managers? Does the program enhance psychological resilience in nurse managers? In this randomized controlled design, participants will be assigned to either an intervention group or a control group. The intervention group will receive a structured empowerment-based psychoeducation program lasting five weeks, while the control group will not receive any intervention. Participants will undergo the following procedures: Completion of baseline (pre-test) assessments (T1) Participation in the psychoeducation program for the intervention group (5 weeks) No intervention for the control group Completion of post-intervention assessments (T2) Completion of follow-up assessments three months after the intervention (T3) The findings of this study are expected to contribute to the development of evidence-based interventions aimed at strengthening managerial competencies and psychological well-being among nurse managers.

NCT Number	NCT07556302
Lead Sponsor	Suleyman Demirel University Collaborators: Kırıkkale University
Conditions	Burnout, Leadership, Psychological Empowerment Program, Psychological Resilience, Mindfulness, Nurse Led Interventions
Enrollment	60 participants
Start Date	2026-06-05
Primary Completion	2026-07-03 (estimated)
Study Completion	2026-10-05 (estimated)
Updated on ClinicalTrials.gov	2026-04-29